Proposed Rule2024-12504
Announcement of Stayed Hearing: Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
June 7, 2024
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Abstract
This is a notification that the Drug Enforcement Administration has stayed the June 10, 2024 hearing on the proposed placement of two phenethylamine hallucinogens, as identified in the proposed rule, in schedule I of the Controlled Substances Act.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 111 (Friday, June 7, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 111 (Friday, June 7, 2024)]
[Proposed Rules]
[Page 48515]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-12504]
========================================================================
Proposed Rules
Federal Register
________________________________________________________________________
This section of the FEDERAL REGISTER contains notices to the public of
the proposed issuance of rules and regulations. The purpose of these
notices is to give interested persons an opportunity to participate in
the rule making prior to the adoption of the final rules.
========================================================================
Federal Register / Vol. 89, No. 111 / Friday, June 7, 2024 / Proposed
Rules
[[Page 48515]]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
21 CFR Part 1308
[Docket No. DEA-1156]
Announcement of Stayed Hearing: Schedules of Controlled
Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-
dimethoxy-4-chloroamphetamine (DOC) in Schedule I
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: Notification of stay of hearing on proposed rulemaking.
-----------------------------------------------------------------------
SUMMARY: This is a notification that the Drug Enforcement
Administration has stayed the June 10, 2024 hearing on the proposed
placement of two phenethylamine hallucinogens, as identified in the
proposed rule, in schedule I of the Controlled Substances Act.
DATES: The hearing will not be taking place on June 10, 2024.
ADDRESSES: Office of the Administrative Law Judges, 8701 Morrissette
Drive, Springfield, Virginia 22152.
FOR FURTHER INFORMATION CONTACT: Hearing Clerk, Debralynn Rosario,
Office of the Administrative Law Judges, 8701 Morrissette Drive,
Springfield, Virginia 22152; Telephone: (571) 362-7035.
SUPPLEMENTARY INFORMATION:
Background
On December 13, 2023, the Drug Enforcement Administration (DEA)
published a Notice of Proposed Rulemaking (NPRM) in the Federal
Register (88 FR 86278) to place two phenethylamine hallucinogen
substances in schedule I of the Controlled Substances Act (CSA) (21
U.S.C. 801, et seq.). Specifically, in this NPRM, DEA proposed to
schedule the following two controlled substances in schedule I of the
CSA, including their salts, isomers, and salts of isomers whenever the
existence of such salts, isomers, and salts of isomers is possible
within the specific chemical designation:
<bullet> 2,5-dimethoxy-4-iodoamphetamine (DOI), and
<bullet> 2,5-dimethoxy-4-chloroamphetamine (DOC).
On April 9, 2024, DEA published a Notice of Hearing on Proposed
Rulemaking (Notice of Hearing) in the FR (89 FR 24750) stating that a
hearing would commence on June 10, 2024. Subsequently, a collateral
matter was filed in a U.S. District Court and the DEA Administrative
Law Judge stayed the administrative hearing proceedings pending a
decision from the U.S. District Court. As the matter before DEA is
currently stayed, no hearing will commence on June 10, 2024.
Signing Authority
This document of the Drug Enforcement Administration was signed on
June 3, 2024, by Administrator Anne Milgram. That document with the
original signature and date is maintained by DEA. For administrative
purposes only, and in compliance with requirements of the Office of the
Federal Register, the undersigned DEA Federal Register Liaison Officer
has been authorized to sign and submit the document in electronic
format for publication, as an official document of DEA. This
administrative process in no way alters the legal effect of this
document upon publication in the Federal Register.
Heather Achbach,
Federal Register Liaison Officer, Drug Enforcement Administration.
[FR Doc. 2024-12504 Filed 6-6-24; 8:45 am]
BILLING CODE 4410-09-P
</pre></body>
</html>Indexed from Federal Register on June 7, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.